In addition, re-expression of functional, endogeneous CXCL12 in CRC cells was shown to reduce metastatic tumor formation significantly while silencing CXCL12 greatly enhanced the metastatic potential of CRC cells [31]. The gene discussed is CXCL12; the disease is colorectal carcinoma.